While transdermal patch delivery systems are under investigation, all commercially available GLP-1 therapies require subcutaneous injection (semaglutide, liraglutide, dulaglutide, tirzepatide) or oral administration (Rybelsus)
As a glucagon-like peptide-1 (GLP-1) receptor agonist, GLP-1 Treatments, Semaglutide or Tirzepatide mimics the action of the body's natural GLP-1 hormone
Talk with your dietitian or prescriber about your specific protein target before adjusting intake
Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases
A new study from the Cleveland Clinic recently explored what happens when people stop taking GLP-1 medications
These large studies did not identify increased fracture risk compared to placebo, providing some reassurance regarding skeletal safety